Suppr超能文献

达纳唑替尼对肝癌HepG2细胞周期、凋亡及自噬的影响

[Effect of danusertib on cell cycle, apoptosis and autophagy of hepatocellular carcinoma HepG2 cells ].

作者信息

Zhu Qiaohua, Luo Meihua, Zhou Chengyu, Chen Zhixian, Huang Wei, Huang Jiangyuan, Zhao Shufeng, Yu Xinfa

机构信息

Department of Oncology, Shunde Hospital of Southern Medical University, Shunde 528308, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2018 Dec 30;38(12):1476-1484. doi: 10.12122/j.issn.1673-4254.2018.12.13.

Abstract

OBJECTIVE

To investigate the effect of danusertib (Danu), an inhibitor of Aurora kinase, on the proliferation, cell cycle, apoptosis, and autophagy of hepatocellular carcinoma HepG2 cells and explore the underlying mechanisms.

METHODS

MTT assay was used to examine the effect of Danu on the viability of HepG2 cells to determine the IC50 of Danu. The effect of Danu on cell cycle distribution, apoptosis and autophagy were determined using flow cytometry. Western blotting was used to detect the expressions of the proteins related to cell cycle, apoptosis and autophagy. Chloroquine was used to suppress Danuinduced autophagy to test the apoptosis-inducing effect of Danu.

RESULTS

Danu significantly inhibited the proliferation of HepG2 cells with IC of 39.4 μmol and 14.4 μmol at 24 h and 48 h, respectively. Danu caused cell cycle arrest in G/M phase in HepG2 cells and led to polyploidy accumulation via up-regulating the expressions of p53 and p21 and down-regulating the expressions of cyclin B1 and DC2. Danu also caused apoptosis of HepG2 cells through up-regulating the expressions of Bax, Puma, cleaved caspase-3, cleaved caspase-9, cleaved PARP and cytochrome C and down-regulating the expressions of Bcl-xl and Bcl-2. Danu induced autophagy via activating AMPK signaling and inhibiting PI3K/PTEN/AKT/mTOR axis, and inhibition of Danu-induced autophagy with chloroquine enhanced the pro-apoptotic effect of Danu.

CONCLUSIONS

Danu inhibits cell proliferation and induces cell cycle arrest in G/M phase, apoptosis and cytoprotective autophagy in HepG2 cells.

摘要

目的

研究极光激酶抑制剂达努昔布(Danu)对肝癌HepG2细胞增殖、细胞周期、凋亡及自噬的影响,并探讨其潜在机制。

方法

采用MTT法检测Danu对HepG2细胞活力的影响,以确定Danu的半数抑制浓度(IC50)。采用流式细胞术检测Danu对细胞周期分布、凋亡和自噬的影响。采用蛋白质印迹法检测与细胞周期、凋亡和自噬相关蛋白的表达。使用氯喹抑制Danu诱导的自噬,以检测Danu的促凋亡作用。

结果

Danu显著抑制HepG2细胞的增殖,在24小时和48小时时的IC50分别为39.4 μmol和14.4 μmol。Danu导致HepG2细胞的细胞周期阻滞于G/M期,并通过上调p53和p21的表达以及下调细胞周期蛋白B1和DC2的表达导致多倍体积累。Danu还通过上调Bax、Puma、裂解的半胱天冬酶-3、裂解的半胱天冬酶-9、裂解的聚(ADP-核糖)聚合酶和细胞色素C的表达以及下调Bcl-xl和Bcl-2的表达,导致HepG2细胞凋亡。Danu通过激活AMPK信号并抑制PI3K/PTEN/AKT/mTOR轴诱导自噬,用氯喹抑制Danu诱导的自噬增强了Danu的促凋亡作用。

结论

Danu抑制HepG2细胞的增殖,并诱导其细胞周期阻滞于G/M期、凋亡和细胞保护性自噬。

相似文献

本文引用的文献

3
The functional diversity of Aurora kinases: a comprehensive review.极光激酶的功能多样性:全面综述
Cell Div. 2018 Sep 19;13:7. doi: 10.1186/s13008-018-0040-6. eCollection 2018.
5
The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma.系统治疗在肝细胞癌管理中的扩展作用。
Can J Gastroenterol Hepatol. 2018 Aug 7;2018:4763832. doi: 10.1155/2018/4763832. eCollection 2018.
7
Review article: systemic treatment of hepatocellular carcinoma.综述文章:肝细胞癌的系统治疗。
Aliment Pharmacol Ther. 2018 Sep;48(6):598-609. doi: 10.1111/apt.14913. Epub 2018 Jul 23.
9
Oral chemotherapy for the treatment of hepatocellular carcinoma.口服化疗药物治疗肝细胞癌。
Expert Opin Pharmacother. 2018 Jun;19(9):993-1001. doi: 10.1080/14656566.2018.1479398. Epub 2018 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验